Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD)

Digestive and Liver Disease

Volumn 40, Issue 5, 2008, Pages 371-378

  Yoneda, M ^a,b   Mawatari, H ^a   Fujita, K ^a   Endo, H ^a   Iida, H ^a   Nozaki, Y ^a   Yonemitsu, K ^a   Higurashi, T ^a   Takahashi, H ^a   Kobayashi, N ^a   Kirikoshi, H ^a   Abe, Y ^a   Inamori, M ^a   Kubota, K ^a   Saito, S ^a   Tamano, M ^b   Hiraishi, H ^b   Maeyama, S ^c   Yamaguchi, N ^a   Togo, S ^a   Nakajima, A ^a   more..

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c Kitakashiwa Rehabilitation Hospital   (Japan)

Author keywords

Fibroscan; Fibrosis; NAFLD; NASH

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; COLLAGEN TYPE 4; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HYALURONIC ACID; INSULIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; ELASTOGRAPHY; FEMALE; GOLD STANDARD; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAPAN; KRUSKAL WALLIS TEST; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MULTIPLE REGRESSION; MULTIVARIATE ANALYSIS; NON INVASIVE MEASUREMENT; NONALCOHOLIC FATTY LIVER; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; THROMBOCYTE COUNT; UNIVERSITY HOSPITAL; VENOUS BLOOD;

BIOPSY; COLLAGEN TYPE VII; DISEASE PROGRESSION; ELASTICITY; ELASTICITY IMAGING TECHNIQUES; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 41849148981     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2007.10.019     Document Type: Article

References (38)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 18 (2002) 1221-1231
2. Farrell G.C. Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?. J Gastroenterol Hepatol 18 (2003) 124-138
3. Diehl A.M., Goodman Z., and Ishak K.G. Alcohol like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 95 (1988) 1056-1062
4. Ludwig J., Viggiano T.R., McGill D.B., and Oh B.J. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55 (1980) 434-438
5. Angulo P., Keach J.C., Batts K.P., and Lindor K.D. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30 (1999) 1356-1362
6. Cadranel J.F. Good clinical practice guidelines for fine needle aspiration biopsy of the liver: past, present and future. Gastroenterol Clin Biol 26 (2002) 823-824
7. Sakugawa H., Nakayoshi T., Kobashigawa K., Yamashiro T., Maeshiro T., Miyagi S., et al. Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease. World J Gastroenterol 11 (2005) 255-259
8. Ratziu V., Giral P., Charlotte F., Bruckert E., Thibault V., Theodorou I., et al. Liver fibrosis in overweight patients. Gastroenterology 118 (2000) 1117-1123
9. Shimada M., Hashimoto E., Kaneda H., Noguchi S., and Hayashi N. Nonalcoholic steatohepatitis: risk factors for liver fibrosis. Hepatol Res 24 (2002) 429-438
10. Sandrin L., Tanter M., Gennisson J.L., Catheline S., and Fink M. Shear elasticity probe for soft tissues with 1-D transient elastography. IEEE Trans Ultrason Ferroelectr Freq Control 49 (2002) 436-446
11. Ziol M., Handra-Luca A., Kettaneh A., Christidis C., Mal F., Kazemi F., et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41 (2005) 48-54
12. Saito H., Tada S., Nakamoto N., Kitamura K., Horikawa H., Kurita S., et al. Efficacy of non-invasive elastometry on staging of hepatic fibrosis. Hepatol Res 29 (2004) 97-103
13. Castera L., Vergniol J., Foucher J., Le Bail B., Chanteloup E., Haaser M., et al. Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128 (2005) 343-350
14. Yoneda M., Fujita K., Inamori M., Nakajima A., Tamano M., and Hiraishi H. Transient elastography in patients with nonalcoholic fatty liver disease (NAFLD). Gut 56 (2007) 1330-1331
15. Sanyal A.J. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123 (2002) 1705-1725
16. Yoshizumi T., Nakamura T., Yamane M., Islam A.H., Menju M., Yamasaki K., et al. Abdominal fat: standardized technique for measurement at CT. Radiology 211 (1999) 283-286
17. Sandrin L., Fourquet B., Hasquenoph J.M., Yon S., Fournier C., Mal F., et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 29 (2003) 1705-1713
18. Matteoni C.A., Younossi Z.M., Gramlich T., Boparai N., Liu Y.C., McCullough A.J., et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116 (1999) 1413-1419
19. Brunt E.M. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 21 (2001) 3-16
20. Imbert-Bismut F., Ratziu V., Pieroni L., Charlotte F., Benhamou Y., Poynard T., et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 357 (2001) 1069-1075
21. Forns X., Ampurdanes S., Llovet J.M., Aponte J., Quinto L., Martinez-Bauer E., et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 36 (2002) 986-992
22. Fung Y.C. Biomechanical properties of living tissues (1981), Springer Verlag, New York
23. Sanyal A.J. Treatment of non-alcoholic fatty liver disease. J Gastroenterol Hepatol 17 Suppl. 3 (2002) S385-S388
24. Saadeh S., Cammell G., Carey W.D., Younossi Z., Barnes D., and Easley K. The role of liver biopsy in chronic hepatitis C. Hepatology 33 (2001) 196-200
25. Poynard T., Ratziu V., and Bedossa P. Appropriateness of liver biopsy. Can J Gastroenterol 14 (2003) 543-548
26. Bedossa P., Dargere D., and Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38 (2003) 1449-1457
27. Maharaj B., Maharaj R.J., Leary W.P., Cooppan R.M., Naran A.D., Pirie D., et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1 (1986) 523-525
28. Regev A., Berho M., Jeffers L.J., Milikowski C., Molina E.G., Pyrsopoulos N.T., et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97 (2002) 2614-2618
29. Soloway R.D., Baggenstoss A.H., Schoenfield L.J., and Summerskill W.H. Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy. Am J Dig Dis 16 (1971) 1082-1086
30. Abdi W., Millan J.C., and Mezey E. Sampling variability on percutaneous liver biopsy. Arch Intern Med 139 (1979) 667-669
31. Ratziu V., Charlotte F., Heurtier A., Gombert S., Giral P., Bruckert E., et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128 (2005) 1898-1906
32. Lindqvist U., and Laurent T.C. Serum hyaluronan and aminoterminal propeptide of type III procollagen: variation with age. Scand J Clin Lab Invest 52 (1992) 613-621
33. Ueno T., Inuzuka S., Torimura T., Oohira H., Ko H., Obata K., et al. Significance of serum type-IV collagen levels in various liver diseases. Measurement with a one-step sandwich enzyme immunoassay using monoclonal antibodies with specificity for pepsin-solubilized type-IV collagen. Scand J Gastroenterol 27 (1992) 513-520
34. Kelleher T.B., MacFarlane C., Ledinghen V., Beaugrand M., Foucher J., Castera L., et al. Risk factors and hepatic elastography (Fibroscan) in the prediction of hepatic fibrosis in non alcoholic steatohepatitis. Gastroenterology 130 (2006) A736
35. Foucher J., Castera L., Bernard P.H., Adhoute X., Laharie D., Bertet J., et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol 18 (2006) 411-412
36. Guechot J., Poupon R.E., Giral P., Balkau B., Giboudeau J., Poupon R., et al. Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C. J Hepatol 20 (1994) 388-393
37. Murawaki Y., Ikuta Y., Koda M., and Kawasaki H. Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology. Hepatology 20 (1994) 780-787
38. Bravo A.A., Sheth S.G., and Chopra S. Liver biopsy. N Engl J Med 344 (2001) 495-500